Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling

To study the physiopathology and significance of asymptomatic airway hyperresponsiveness (AHR), the clinical and bronchial immunohistological parameters were evaluated in subjects with asymptomatic and symptomatic AHR. Asymptomatic subjects with AHR (eight females/two males, no respiratory symptoms, provocative concentration of methacholine causing a 20% fall in forced expiratory volume in one second (PC20) <8 mg x mL(-1) and no treatment) were compared with asthmatic subjects paired for age, sex and PC20, and with nonatopic, nonasthmatic controls paired for age and sex. All three groups were evaluated once at baseline, whilst the asymptomatic AHR subjects were re-evaluated after 1 and 2 yrs. Measurements included spirometry, methacholine challenge, serum immunoglobulin (Ig)E, blood eosinophils, and bronchoscopy (at baseline and after 2 yrs only). At first evaluation, the mean blood eosinophil count, total serum IgE level, atopic index, baseline forced expiratory volume in one second (FEV1) and the degree of bronchial epithelial desquamation of the asymptomatic AHR subjects were similar to those of asthmatic subjects. However, they presented focal rather than the continuous bronchial subepithelial fibrosis observed in asthmatics. Their mucosal CD3, CD4, CD25, EG1 and EG2-positive cell counts were intermediate between those of the control subjects and asthmatics. At the end of the 2-yr follow-up, four of them had developed asthma symptoms. At this time, bronchial biopsies revealed an increase in the extent of subepithelial fibrosis and in the number of CD25 and CD4-positive cells, and a decrease in the number of CD8+ cells, particularly in subjects who developed asthma symptoms. These data suggest that asymptomatic airway hyperresponsiveness is associated with airway inflammation and remodelling, and that the appearance of asthma symptoms is associated with an increase in these features, particularly the CD4/CD8 ratio and airway fibrosis. Consequently, this study proposes an association between asymptomatic airway hyperresponsiveness and airway inflammation, structural changes and asthma although these relationships remain to be further evaluated.

This article has been cited by other articles:

				L-P. Boulet Asymptomatic airway hyperresponsiveness: what does it mean? Eur. Respir. J., October 1, 2008; 32(4): 1118 - 1119. [Full Text] [PDF]

				D. S. Southam, R. Ellis, J. Wattie, S. Young, and M. D. Inman Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Eur. Respir. J., October 1, 2008; 32(4): 970 - 978. [Abstract] [Full Text] [PDF]

				L. van den Nieuwenhof, T. Schermer, Y. Heijdra, B. Bottema, R. Akkermans, H. Folgering, and C. van Weel Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study Eur. Respir. J., July 1, 2008; 32(1): 70 - 76. [Abstract] [Full Text] [PDF]

				M Imboden, T Rochat, M Brutsche, C Schindler, S H Downs, M W Gerbase, W Berger, N M Probst-Hensch, and the SAPALDIA Team Glutathione S-transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults Thorax, April 1, 2008; 63(4): 322 - 328. [Abstract] [Full Text] [PDF]

				L-P. Boulet and P. J. Sterk Airway remodelling: the future Eur. Respir. J., November 1, 2007; 30(5): 831 - 834. [Full Text] [PDF]

				K Boutet, J-L Malo, H Ghezzo, and D Gautrin Airway hyperresponsiveness and risk of chest symptoms in an occupational model Thorax, March 1, 2007; 62(3): 260 - 264. [Abstract] [Full Text] [PDF]

				L-P. Boulet and P. J. Sterk A new series on airway remodelling Eur. Respir. J., February 1, 2007; 29(2): 231 - 232. [Full Text] [PDF]

				A. Shibata, T. Katsunuma, M. Tomikawa, A. Tan, K. Yuki, K. Akashi, and Y. Eto Increased Leukotriene E4 in the Exhaled Breath Condensate of Children With Mild Asthma Chest, December 1, 2006; 130(6): 1718 - 1722. [Abstract] [Full Text] [PDF]

				M H Brutsche, S H Downs, C Schindler, M W Gerbase, J Schwartz, M Frey, E W Russi, U Ackermann-Liebrich, P Leuenberger, and for the SAPALDIA Team Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study Thorax, August 1, 2006; 61(8): 671 - 677. [Abstract] [Full Text] [PDF]

				C. Bergeron and L.-P. Boulet Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest, April 1, 2006; 129(4): 1068 - 1087. [Abstract] [Full Text] [PDF]

				C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF]

				K. B. Moerloose, R. A. Pauwels, and G. F. Joos Short-Term Cigarette Smoke Exposure Enhances Allergic Airway Inflammation in Mice Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 168 - 172. [Abstract] [Full Text] [PDF]

				T. C. Fardon and B. J. Lipworth An Own GOAL or a Real Breakthrough? Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1060 - 1060. [Full Text] [PDF]

				R. Leigh, D. S. Southam, R. Ellis, J. N. Wattie, R. Sehmi, Y. Wan, and M. D. Inman T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice J Appl Physiol, December 1, 2004; 97(6): 2258 - 2265. [Abstract] [Full Text] [PDF]

				R. Leigh, R. Ellis, J. Wattie, D. D. Donaldson, and M. D. Inman Is Interleukin-13 Critical in Maintaining Airway Hyperresposiveness in Allergen-challenged Mice? Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 851 - 856. [Abstract] [Full Text] [PDF]

				D. C. Grootendorst and K. F. Rabe Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87. [Abstract] [Full Text] [PDF]

				R. Leigh, R. Ellis, J. N. Wattie, J. A. Hirota, K. I. Matthaei, P. S. Foster, P. M. O'Byrne, and M. D. Inman Type 2 Cytokines in the Pathogenesis of Sustained Airway Dysfunction and Airway Remodeling in Mice Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 860 - 867. [Abstract] [Full Text] [PDF]

				S. J. Wadsworth, A. M. Freyer, R. L. Corteling, and I. P. Hall Biosynthesized matrix provides a key role for survival signaling in bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L596 - L603. [Abstract] [Full Text] [PDF]

				J. R. Johnson, R. E. Wiley, R. Fattouh, F. K. Swirski, B. U. Gajewska, A. J. Coyle, J.-C. Gutierrez-Ramos, R. Ellis, M. D. Inman, and M. Jordana Continuous Exposure to House Dust Mite Elicits Chronic Airway Inflammation and Structural Remodeling Am. J. Respir. Crit. Care Med., February 1, 2004; 169(3): 378 - 385. [Abstract] [Full Text] [PDF]

				S.T. Holgate, D. E. Davies, S. Puddicombe, A. Richter, P. Lackie, J. Lordan, and P. Howarth Mechanisms of airway epithelial damage: epithelial-mesenchymal interactions in the pathogenesis of asthma Eur. Respir. J., September 20, 2003; 22(44_suppl): 24s - 29s. [Full Text] [PDF]

				B. E. McParland, P. T. Macklem, and P. D. Pare Airway wall remodeling: friend or foe? J Appl Physiol, July 1, 2003; 95(1): 426 - 434. [Abstract] [Full Text] [PDF]

				L.-P. Boulet Asymptomatic Airway Hyperresponsiveness: A Curiosity or an Opportunity to Prevent Asthma? Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 371 - 378. [Full Text] [PDF]

				X. Ma, Z. Cheng, H. Kong, Y. Wang, H. Unruh, N. L. Stephens, and M. Laviolette Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1181 - L1189. [Abstract] [Full Text] [PDF]

				R. Leigh, R. Ellis, J. Wattie, D. S. Southam, M. de Hoogh, J. Gauldie, P. M. O'Byrne, and M. D. Inman Dysfunction and Remodeling of the Mouse Airway Persist after Resolution of Acute Allergen-Induced Airway Inflammation Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 526 - 535. [Abstract] [Full Text] [PDF]

				K. Shiba, K. Kasahara, H. Nakajima, and M. Adachi Structural Changes of the Airway Wall Impair Respiratory Function, Even in Mild Asthma Chest, November 1, 2002; 122(5): 1622 - 1626. [Abstract] [Full Text] [PDF]

				O. J. Dempsey, S. J. Fowler, A. Wilson, G. Kennedy, and B. J. Lipworth Effects of Adding Either a Leukotriene Receptor Antagonist or Low-Dose Theophylline to a Low or Medium Dose of Inhaled Corticosteroid in Patients With Persistent Asthma* Chest, July 1, 2002; 122(1): 151 - 159. [Abstract] [Full Text] [PDF]

				F. Rasmussen, D. R. Taylor, E. M. Flannery, J. O. Cowan, J. M. Greene, G. P. Herbison, and M. R. Sears Risk Factors for Airway Remodeling in Asthma Manifested by a Low Postbronchodilator FEV1/Vital Capacity Ratio: A Longitudinal Population Study from Childhood to Adulthood Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1480 - 1488. [Abstract] [Full Text] [PDF]

				E. Palmans, N. J. Vanacker, R. A. Pauwels, and J. C. Kips Effect of Age on Allergen-induced Structural Airway Changes in Brown Norway Rats Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1280 - 1284. [Abstract] [Full Text] [PDF]

				C Ward, M Pais, R Bish, D Reid, B Feltis, D Johns, and E H Walters Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax, April 1, 2002; 57(4): 309 - 316. [Abstract] [Full Text] [PDF]

				M. Milanese, E. Crimi, A. Scordamaglia, A. Riccio, R. Pellegrino, G. W. Canonica, and V. Brusasco On the functional consequences of bronchial basement membrane thickening J Appl Physiol, September 1, 2001; 91(3): 1035 - 1040. [Abstract] [Full Text] [PDF]

				K. Blease, C. Jakubzick, J. Westwick, N. Lukacs, S. L. Kunkel, and C. M. Hogaboam Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma J. Immunol., April 15, 2001; 166(8): 5219 - 5224. [Abstract] [Full Text] [PDF]

				L.-P. BOULET, H. TURCOTTE, M. LAVIOLETTE, F. NAUD, M.-C. BERNIER, S. MARTEL, and J. CHAKIR Airway Hyperresponsiveness, Inflammation, and Subepithelial Collagen Deposition in Recently Diagnosed versus Long-standing Mild Asthma . Influence of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1308 - 1313. [Abstract] [Full Text] [PDF]

				S. J. FOWLER, O. J. DEMPSEY, E. J. SIMS, and B. J. LIPWORTH Screening for Bronchial Hyperresponsiveness Using Methacholine and Adenosine Monophosphate . Relationship to Asthma Severity and beta 2-Receptor Genotype Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1318 - 1322. [Abstract] [Full Text] [PDF]

				L. M. van den TOORN, J.-B. PRINS, S. E. OVERBEEK, H. C. HOOGSTEDEN, and J. C. de JONGSTE Adolescents in Clinical Remission of Atopic Asthma Have Elevated Exhaled Nitric Oxide Levels and Bronchial Hyperresponsiveness Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 953 - 957. [Abstract] [Full Text]